Over 155,000 adults in the UK are estimated to have the disease, with 40% of them having moderate or severe symptoms
Around 5,500 people in England are diagnosed with the aggressive blood cancer each year
The rare autoimmune disease affects two to ten people per million and has limited treatments
This haematological malignancy is the third most common in Europe and the US and is incurable for most patients
This makes Dupixent the first and only targeted medicine indicated for this condition